Impact of HIV on CD8+ T Cell CD57 Expression Is Distinct from That of CMV and Aging
Open Access
- 27 February 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (2) , e89444
Abstract
Chronic antigenic stimulation by cytomegalovirus (CMV) is thought to increase “immunosenesence” of aging, characterized by accumulation of terminally differentiated CD28- CD8+ T cells and increased CD57, a marker of proliferative history. Whether chronic HIV infection causes similar effects is currently unclear. We compared markers of CD8+ T cell differentiation (e.g., CD28, CD27, CCR7, CD45RA) and CD57 expression on CD28- CD8+ T cells in healthy HIV-uninfected adults with and without CMV infection and in both untreated and antiretroviral therapy (ART)-suppressed HIV-infected adults with asymptomatic CMV infection. Compared to HIV-uninfected adults without CMV (n = 12), those with asymptomatic CMV infection (n = 31) had a higher proportion of CD28-CD8+ T cells expressing CD57 (P = 0.005). Older age was also associated with greater proportions of CD28-CD8+ T cells expressing CD57 (rho: 0.47, P = 0.007). In contrast, untreated HIV-infected CMV+ participants (n = 55) had much lower proportions of CD28- CD8+ cells expressing CD57 than HIV-uninfected CMV+ participants (PTR) CD8+ T cells (P<0.0001). Chronically HIV-infected adults maintaining ART-mediated viral suppression (n = 96) had higher proportions of CD28-CD8+ T cells expressing CD57 than untreated patients (P<0.0001), but continued to have significantly lower levels than HIV-uninfected controls (P = 0.001). Among 45 HIV-infected individuals initiating their first ART regimen, the proportion of CD28-CD8+ T cells expressing CD57 declined (P<0.0001), which correlated with a decline in percent of transitional memory CD8+ T cells, and appeared to be largely explained by a decline in CD28-CD57- CD8+ T cell counts rather than an expansion of CD28-CD57+ CD8+ T cell counts. Unlike CMV and aging, which are associated with terminal differentiation and proliferation of effector memory CD8+ T cells, HIV inhibits this process, expanding less well-differentiated CD28- CD8+ T cells and decreasing the proportion of CD28- CD8+ T cells that express CD57.Keywords
This publication has 36 references indexed in Scilit:
- Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expressionBlood, 2011
- T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected WomenThe Journal of Infectious Diseases, 2011
- Cytomegalovirus-Specific T Cells Persist at Very High Levels during Long-Term Antiretroviral Treatment of HIV DiseasePLOS ONE, 2010
- Aging and Infectious Diseases: Workshop on HIV Infection and Aging: What Is Known and Future Research DirectionsClinical Infectious Diseases, 2008
- The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20–100 years of ageBiogerontology, 2008
- No Immune Risk Profile among individuals who reach 100 years of age: Findings from the Swedish NONA immune longitudinal studyExperimental Gerontology, 2007
- Role of persistent CMV infection in configuring T cell immunity in the elderlyImmunity & Ageing, 2007
- Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 InfectionPLOS Biology, 2004
- Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cellsBlood, 2003
- Immune Parameters in a Longitudinal Study of a Very Old Population of Swedish People: A Comparison Between Survivors and NonsurvivorsThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 1995